High-dose naloxone formulations are not as essential as we thought

• Main Authors: Paige M. Lemen (Author), Daniel P. Garrett (Author), Erin Thompson (Author), Megan Aho (Author), Christina Vasquez (Author), Ju Nyeong Park (Author)
• Format: Book
• Published: BMC, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Naloxone is an effective FDA-approved opioid antagonist for reversing opioid overdoses. Naloxone is available to the public and can be administered through intramuscular (IM), intravenous (IV), and intranasal spray (IN) routes. Our literature review investigates the adequacy of two doses of...